Clinical Trial Update: Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neratinib in combination with chemotherapy, trastuzumab, and pembrolizumab for HER2-positive gastroesophageal cancer is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• Trastuzumab (trastuzumab)
• neratinib (neratinib)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: GastroEsophageal Cancer, Gastric Cancer | Phase 2 | Status: RECRUITING